Calamos Advisors’s Ametek AME Stock Holding History

Calamos Advisors’s Portfolio AME Stock Details AME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,206	Closed	-$259K	–	993
2026 Q1	$259K	Buy	+1,206	New	+$268K	﹤0.01%	1072

Other funds holding AME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Calamos Advisors's AME Position: Q2 2026 in Review

Calamos Advisors sold out of Ametek (AME) in Q2 2026, closing a stake of 1,206 shares — an estimated $259K sold.

Calamos Advisors first reported a position in AME in Q1 2026 and held it in 1 quarter. The position peaked at $259K in Q1 2026. 1,198 funds tracked by Wall St. Rank hold AME as of Q2 2026.

Calamos Advisors reported no remaining Ametek position as of Q2 2026 after selling out during the quarter.
Calamos Advisors sold 1,206 Ametek shares in Q2 2026, an estimated $259K.
Calamos Advisors first reported a position in Ametek in Q1 2026 and held it in 1 quarter.
Calamos Advisors's Ametek position peaked at $259K in Q1 2026.
1,198 funds tracked by Wall St. Rank held Ametek as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.